BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonnemeier H, Huelsebeck M, Kloss S. Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study. Int J Cardiol Heart Vasc 2019;23:100367. [PMID: 31111087 DOI: 10.1016/j.ijcha.2019.100367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Magnusson P, V. Pergolizzi Jr J, K. Wolf R, Lamberts M, Ann Lequang J. Anticoagulation in Atrial Fibrillation Patients. In: Cismaru G, Andrew Chan K, editors. Epidemiology and Treatment of Atrial Fibrillation. IntechOpen; 2020. [DOI: 10.5772/intechopen.88965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Grandone E, Aucella F, Barcellona D, Brunori G, Forneris G, Gresele P, Marietta M, Poli D, Testa S, Tripodi A, Genovesi S. Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET). J Nephrol 2021;34:31-8. [PMID: 32757171 DOI: 10.1007/s40620-020-00768-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cases A, Gomez P, Broseta JJ, Perez Bernat E, Arjona Barrionuevo JD, Portolés JM, Gorriz JL. Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review. Front Med (Lausanne) 2021;8:654620. [PMID: 34604247 DOI: 10.3389/fmed.2021.654620] [Reference Citation Analysis]
4 Pavlova TV. Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;17:916-26. [DOI: 10.20996/1819-6446-2021-12-08] [Reference Citation Analysis]
5 Grandone E, Aucella F, Barcellona D, Brunori G, Forneris G, Gresele P, Marietta M, Poli D, Testa S, Tripodi A, Genovesi SC. Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET. Blood Transfus 2020;18:478-85. [PMID: 33000751 DOI: 10.2450/2020.0156-20] [Reference Citation Analysis]
6 Zeymer U, Bonnemeier H, Wanner C. [Safety and effectiveness of oral anticoagulation in patients with atrial fibrillation and renal insufficiency - a real-world perspective]. Dtsch Med Wochenschr 2022;147:617-24. [PMID: 35545071 DOI: 10.1055/a-1792-7094] [Reference Citation Analysis]